wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33812170-0ECC543B-51F7-4EB8-9FC8-2E7AC8B32F67
Q33812170-0ECC543B-51F7-4EB8-9FC8-2E7AC8B32F67
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33812170-0ECC543B-51F7-4EB8-9FC8-2E7AC8B32F67
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)
P2860
Q33812170-0ECC543B-51F7-4EB8-9FC8-2E7AC8B32F67
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33812170-0ECC543B-51F7-4EB8-9FC8-2E7AC8B32F67
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
47aec9d9a35c0e2611f5cc005d41de48c1e7edb2
P2860
Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial